Carcinogenesis, Vol. 20, No. 2, 279-284,
February 1999
© 1999 Oxford University Press
Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell
Division of Hematology and Oncology, Department of Medicine and the University/Ireland Cancer Research Center, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, BRB-3, 10900 Euclid Avenue, Cleveland, OH 44106-4937, USA
Human methylguanine–DNA methyltransferase (MGMT) transgenic mice expressing high levels of O6-alkylguanine-DNA alkyltransferase (AGT) in lung were crossbred to A/J mice that are susceptible to pulmonary adenoma to study the impact of O6-methylguanine (O6mG)–DNA adduct repair on NNK-induced lung tumorigenesis. Expression of the chimeric human MGMT transgene in lung was identified by northern and western blot analysis, immunohistochemistry assay and enzymatic assay. AGT activity was 17.6 ± 3.2 versus 1.2 ± 0.4 fmol/µg DNA in lung of MGMT transgenic mice compared with non-transgenic mice. Immunohistochemical staining with anti-human AGT antibody showed that human AGT was expressed throughout the lung. However, some epithelial cells of bronchi and alveoli did not stain for human AGT, suggesting that the human MGMT transgene expression was heterogeneous. After 100 mg/kg NNK i.p. injection in MGMT transgenic mice, lung AGT activity remained much higher and levels of lung O6mG–DNA adducts in MGMT transgenic mice were lower than those of non-transgenic mice. In the tumorigenesis study, mice received 100 mg/kg NNK at 6 weeks of age and were killed 44 weeks later. Ten of 17 MGMT transgenic mice compared with 16 of 17 non-transgenic mice had lung tumors, P < 0.05. MGMT transgenic mice had lower multiplicity and smaller sized lung tumors than non-transgenic mice. Moreover, a reduction in the frequency of K-ras mutations in lung tumors was found in MGMT transgenic mice (6.7 versus 50% in non-transgenic mice). These results indicate that high levels of AGT expressed in mouse lung reduce lung tissue susceptibility to NNK-induced tumorigenesis due to increased repair capacity for O6mG, subsequently, decreased mutational activation of K-ras oncogene. Heterogeneity in the level of AGT expressed in different lung cell populations or other forms of carcinogenic DNA damage caused by NNK may explain the residual incidence of lung tumors in MGMT transgenic mice.
Abbreviations: AGT, alkyltransferase; ECL, enhanced chemiluminescence; hAGT, human AGT; hMGMT, human MGMT; MGMT, O6-methylguanine–DNA methyltransferase; MNU, N-methylnitrosourea; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; O6mG, O6-methylguanine; PBS, phosphate-buffered saline; TBS, Tris-buffered saline.
1 To whom correspondence should be addressed Email: slg5{at}po.cwru.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-C. LAI, J.-Y. WU, Y.-W. CHENG, K.-T. YEH, T.-C. WU, C.-Y. CHEN, and H. LEE O6-Methylguanine-DNA Methyltransferase Hypermethylation Modulated by 17{beta}-Estradiol in Lung Cancer Cells Anticancer Res, July 1, 2009; 29(7): 2535 - 2540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Sandercock, J. N. Hahn, L. Li, H.A. Luchman, J. L. Giesbrecht, L. A. Peterson, and F. R. Jirik Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carcinogenesis, April 1, 2008; 29(4): 866 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Niture, C. S. Velu, Q. R. Smith, G.J. Bhat, and K. S. Srivenugopal Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines Carcinogenesis, February 1, 2007; 28(2): 378 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rinne, D. Caldwell, and M. R. Kelley Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells Mol. Cancer Ther., August 1, 2004; 3(8): 955 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, W. Lu, X. Miao, D. Xing, W. Tan, and D. Lin Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma Carcinogenesis, June 1, 2003; 24(6): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Klatt and M. Serrano Engineering cancer resistance in mice Carcinogenesis, May 1, 2003; 24(5): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Becker, C. Gregel, C. Fricke, D. Komitowski, J. Dosch, and B. Kaina DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors Carcinogenesis, March 1, 2003; 24(3): 541 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Gerson Clinical Relevance of MGMT in the Treatment of Cancer J. Clin. Oncol., May 1, 2002; 20(9): 2388 - 2399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Wolf, Y. C. Hu, K. Doffek, D. Sidransky, and S. A. Ahrendt O6-Methylguanine-DNA Methyltransferase Promoter Hypermethylation Shifts the p53 Mutational Spectrum in Non-Small Cell Lung Cancer Cancer Res., November 1, 2001; 61(22): 8113 - 8117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Q. Zhou, D. Manguino, K. Kewitt, G. W. Intano, C. A. McMahan, D. C. Herbert, M. Hanes, R. Reddick, Y. Ikeno, and C. A. Walter Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase PNAS, October 12, 2001; (2001) 221232998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis Cancer Res., August 1, 2001; 61(15): 5757 - 5763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu, T. P. Spiro, X. Qin, S. Majka, J. Haaga, J. Schupp, J. K. V. Willson, and S. L. Gerson Differential Degradation Rates of Inactivated Alkyltransferase in Blood Mononuclear Cells and Tumors of Patients after Treatment with O6-Benzylguanine Clin. Cancer Res., August 1, 2001; 7(8): 2318 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, R.-A. Risques, M. Toyota, G. Capella, V. Moreno, M. A. Peinado, S. B. Baylin, and J. G. Herman Promoter Hypermethylation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase Is Associated with the Presence of G:C to A:T Transition Mutations in p53 in Human Colorectal Tumorigenesis Cancer Res., June 1, 2001; 61(12): 4689 - 4692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wu, M. R. Kelley, W. K. Hansen, and W. J. Martin II Reduction of BCNU toxicity to lung cells by high-level expression of O6-methylguanine-DNA methyltransferase Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L755 - L761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, M. Toyota, M. Sanchez-Cespedes, G. Capella, M. A. Peinado, D. N. Watkins, J.-P. J. Issa, D. Sidransky, S. B. Baylin, and J. G. Herman Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation Is Associated with G to A Mutations in K-ras in Colorectal Tumorigenesis Cancer Res., May 1, 2000; 60(9): 2368 - 2371. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-Q. Zhou, D. Manguino, K. Kewitt, G. W. Intano, C. A. McMahan, D. C. Herbert, M. Hanes, R. Reddick, Y. Ikeno, and C. A. Walter Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase PNAS, October 23, 2001; 98(22): 12566 - 12571. [Abstract] [Full Text] [PDF]
|
|